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radiation exposure  on  endogenous  bone marrow (BM) and 
splenic  granulocyte-macrophage  colony-stimulating  factor 
(GM-CSF)  and  transforming growth factor-@  (TGF-@)  mRNA 
levels were assayed in BBD2F1 female mice. BM and  spleen 
were harvested from normal mice  and irradiated mice on 
days 2,4.7,10. and  14  after  exposure.  Cytokine  mRNA  levels 
were determined using  reverse  transcription-polymerase 
chain  reaction.  After  irradiation,  GM-CSF  mRNA  levels  were 
significantly  increased in the  BM from days  2 to 10  and in 
the spleen from days  4 to 10.  However, when BM and  splenic 
GM-CSF protein levels were measured  using  Western  dot 
T 
HE BONE MARROW (BM) and the spleen have been 
recognized as important hematopoietic organs in the 
mouse containing both multipotential stem cells and a variety 
of committed progenitor cells. It  is known that endogenously 
produced cytokines regulate hematopoietic stem and progen- 
itor cell proliferation, differentiation, and function. Granulo- 
cyte-macrophage colony-stimulating factor (GM-CSF) is a 
hematopoietic cytokine with a specific ability to stimulate 
proliferation and maturation of granulocyte and macrophage 
myeloid cells.’ A number of different cell types are able 
to synthesize and release GM-CSF, such as macrophages, 
endothelial cells, fibroblasts and stromal cells.’ Transforming 
growth factor$ (TGF-P) is a multifunctional cytokine that 
has the ability to inhibit or stimulate the proliferation of 
hematopoietic progenitor cells. Goey et a13 showed that fem- 
oral artery infusion of TGF-P, into normal animals partially 
inhibited interleukin-3 (IL-3)-induced colony-forming unit- 
erythroid (CFU-e) and completely prevented IL-3-induced 
colony-forming unit-granulocyte, erythroid, monocyte, meg- 
akaryocyte (CFU-GEMM) formation. On the other hand, 
Keller et a14 showed that TGF-P can increase the differentia- 
tion of neutrophils in suspension cultures when  used in com- 
bination with GM-CSF and also showed that the same com- 
bination increases granulocyte-macrophage colony-forming 
cells (GM-CFC) in 5-fluorouracil-treated BM. This cyto- 
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blot.  no  increased protein levels were detected.  Serum GM- 
CSF levels were likewise unchanged.  Radiation  exposure  did 
not affect BM or  splenic  TGF-fl  mRNA  levels  and this cyto- 
kine is known to be produced  by  cell  populations  similar to 
those that produce  GM-CSF.  These data suggest that radia- 
tion injury to hemopoietic  tissues  results in differential  ef- 
fects  on  GM-CSF  and  TGF-@  mRNA  levels  and that, in the 
case of GM-CSF,  increased mRNA levels are not matched  by 
increased protein production. 
This  is a US government  work.  There  are no restrictions  on 
its use. 
kine is also known to be produced by a number of different 
cell types, including endothelial cells, monocytes, fibro- 
blasts, epidermis, chondrocytes, and epithelial cells.’ 
In  in vitro systems, expression of GM-CSF mRNA  and 
production of GM-CSF protein have been shown to increase 
in response to stimulation with chemical and physical agents. 
In  the MLA-144 T-cell line, which does not exhibit a detect- 
able basal GM-CSF mRNA level, an increase in GM-CSF 
mRNA level was detected when cells were stimulated with 
phorbol 12-myristate 13-a~etate.~  Murine BM cells treated 
with the tumor-promoting phorbol ester 12-0-tetradecanoyl- 
phorbol- 13-acetate (TPA) and lipopolysaccharide (LPS) 
have  been  shown to exhibit increased levels of GM-CSF 
pr~tein.~  Very  high levels of TGF-P mRNA  were also shown 
to be induced in mouse epidermal cells treated  with TPA.X 
Furthermore, increases in  the production of GM-CSF protein 
have been observed in murine long-term BM  cultures’.“’  and 
in spleen cell cultures’’ after in vitro irradiation. Increases 
in the production of TGF-,& protein  have also been found in 
rabbit lung alveolar macrophage cell cultures after irradia- 
tion.” Using a murine radiation model  in  which a high suble- 
thal radiation exposure was  used  to induce severe hematopoi- 
etic hypoplasia, we have evaluated the effects of radiation 
on endogenous GM-CSF and TGF-,& mRNA levels in vivo. 
MATERIALS AND METHODS 
Mice. BhD2FI female mice (approximately 20 g) were purchased 
from Jackson Laboratories (Bar Harbor, ME). Mice were maintained 
in a facility accredited by American Association for the Accredita- 
tion  of Laboratory Animal Care (AAALAC) in Micro-Isolator cages 
on hardwood-chip contact bedding and were provided commercial 
rodent chow and acidified water (pH 2.5) ad libitum. Animal rooms 
were equipped with full-spectrum light from 0600 to 1800 hours 
and were maintained at  21°C ? 1°C and 50% ? 10% relative humid- 
ity with at least 10 air changes per hour of 100% conditioned fresh 
air. On arrival, all mice were tested for Pseudomonas and quaran- 
tined until test results were obtained. Only healthy mice were re- 
leased for experimentation. All animal experiments were approved 
by the Institute Animal Care and Use Committee before they were 
performed. 
Irradiation. The “CO source  at the Armed Forces Radiobiology 
Research Institute (AFRRI) was used to administer bilateral total- 
body gamma radiation. Mice were placed in ventilated Plexiglas 
containers and sublethally irradiated at a dose of 775 cGy. Dosimetry 
was performed using ionization chambers as previously described,” 
with calibration factors traceable to the National Institute of Stan- 
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dards and Technology. Before experiments were initiated, the dose 
rate  at  the  midline  of  an  acrylic  mouse phantom  was  measured 
with a 0.5-mL tissue-equivalent ionization chamber manufactured 
by  Exradin  (Lisle, IL). Before each  experimental irradiation, the 
dose rate at the same location with the phantom removed was mea- 
sured with a 50-mL ionization chamber fabricated at AFRRI. The 
ratio of  these two dose rates, the tissue-air ratio (TAR), was then 
used to ensure delivery of  the  midline dose desired for each animal 
exposure. The TAR in these experiments was 0.96, and dose varia- 
tion within the exposure field  was  less than 3%. 
Cells  and  tissues.  Femurs and spleens were harvested from nor- 
mal and irradiated mice on days 2, 4, 7,  10, and  14 postirradiation 
after euthanization by cervical dislocation. Tissues from 3 to 7 mice 
were pooled to obtain sufficient cells for each specific assay. BM 
cells were flushed from femurs with 3.0 mL of McCoy's 5A medium 
(Flow Labs, McLean, VA) containing  10% heat-inactivated fetal 
bovine serum (Hyclone Labs, Logan, UT). In  mRNA  and  protein 
studies, spleens were homogenized with a polytron homogenizer. 
For cell culture studies, spleens were pressed through a stainless 
steel mesh screen, and the cells were washed from the screen with 
6.0 mL of  McCoy's  5A medium. The number of  nucleated cells in 
the BM  and  splenic suspensions was determined using a Coulter 
counter (Coulter, Hialeah, FL). To obtain serum from normal and 
irradiated mice on days 2,4, 8, 10,  14, and 17 postexposure, animals 
were halothane-anesthesized and blood was drawn by cardiac punc- 
ture using a syringe attached to a 20-gauge needle. 
Reverse  transcription-polymerase  chain  reaction  (RT-PCR)  and 
Soufhern  blotting.  Total RNA was extracted from BM suspensions 
and homogenized spleens using the RNAzol method (Tel-Test Inc, 
Friendswood, TX)  as  modified  from  Chomczynski and  Sacchi.15 
RNA concentrations were determined spectrophotometrically from 
absorbance at 260 nm. Total RNA of each sample was characterized 
by ethidium bromide staining of  agarose gels to ensure use of only 
intact RNA. Intact total RNA was reversely transcribed into first- 
strand cDNA, which was then amplified using PCR. The final vol- 
ume of  5 pL RT reaction mixture contained 0.1 pg BM total RNA 
or 0.5 pg splenic total RNA; 50 mmoVL Tris-HCI (pH 8.3);  3 mmoV 
L  MgCI2; 75  mmo1L  KCI;  2.5  pg/mL oligo(dT)12.,s; 1 mmoVL 
each of dATP, dGTP, dTTP, and dCTP; and 10 U Moloney murine 
leukemia virus RT. The reaction mixture for RT was incubated at 
37°C for  1 hour and  at  90°C  for 10  minutes and chilled on ice for 
10 minutes. The PCR primers for GM-CSF, TGF-P, or glyceralde- 
hyde-3-phosphate dehydrogenase (GAPDH) mRNA were purchased 
from Clontech Laboratories, Inc (Palo Alto, CA). The sequence of 
primers and  expected product size are described in Table  1. The 
reaction mixture for PCR contained 5 pL cDNA template from the 
RT reaction; 10 mmoVL Tris-HC1 (pH 8.3); 50 mmollL KCI; 1.5 
mmolL MgC1,;  0.8 mmol/L each of dATP, dGTP, dTTP, and dCTP, 
1.0 pmom 5"primer;  1.0 pmoVL  3"primer;  and 1.25 U Taq DNA 
polymerase. PCR  was performed with a DNA Thermal Cycler (Per- 
kin Elmer-Cetus, Norwalk, CT) at 94°C for I minute, at  60°C  for 2 
Table 1. Sequence of Amplimer Set for Murine Cytokines 
Cytokine 
Fragment 
Sequence  (bp) 
GM-CSF 
5"primer  5'-TGTGGTCTACAGCCTCTCAGCAC-3'  368" 
3"primer  5'-CAAAGGGGATATCAGTCAGAAAGGT-3'  1964t 
5-primer  5'-TGGACCGCAACAACGCCATCTATGAGAAAACC-3'  525 
3'-primer  5'-TGGAGCTGAAGCAATAGlTGGTATCCAGGGCT-3' 
3'-primer  5'-CAAAGlTGTCATGGATGACC-3' 
5"primer  5'-CCATGGAGAAGGCTGGGG-3' 
TGF-p 
GAPDH 
195 
minutes, and  at  72 "C  for 3 minutes per cycle until the optimum 
number of cycles was reached. The amplified products were electro- 
phoresed in a 1% agarose gel in the presence of  1 pg/mL ethidium 
bromide, transferred onto Nytran membrane (Schleicher & Schuell, 
Keene,  NH),  and  hybridized  with  32P-labeled murine  GM-CSF, 
TGF-P, and GAPDH probes. The probes were "P-labeled  with  a 
nick-translation commercial kit  (Bethesda Research Laboratories, 
Gaithersburg, MD). The steps of hybridization were as follows. Pre- 
hybridization  was  performed  in  a  solution  containing  50%  for- 
mamide solution, 6x  SSC, 5X Denhardt's, 50 mmoVL Tris, 100 pgl 
mL salmon sperm DNA, and  1%  sodium dodecyl sulfate (SDS) at 
42°C; overnight hybridization was performed in the same solution 
after the addition of its respective 32P-labeled  cytokine probe. Subse- 
quently, blots were washed three times at 42°C in a solution con- 
taining 2x SSC and 0.5% SDS and  finally  at 62°C  in  a solution 
containing 0.1~  SSC and 0.1%  SDS for  1  hour. Autoradiography 
was performed at  -70°C  using Kodak XAR  film  (Eastman Kodak, 
Rochester, NY). 
GM-CFC assay.  BM  and  splenic hematopoietic progenitor cells 
committed to granulocyte and/or macrophage development were as- 
sayed using a double-layer agar GM-CFC assay.14 Mouse endotoxin 
serum (5%  vol/vol) was added to feeder layers as a source of colony- 
stimulating factors. Colonies (>50 cells) were counted after 10 days 
of incubation in a 37°C  humidified environment containing 5% COz. 
Triplicate plates were cultured for each cell suspension, and experi- 
ments  were repeated three  times. A  similar procedure was  used 
to evaluate colony-stimulating activity in serum from normal and 
irradiated mice. In these studies 5% or 10% (voVvol) of  test serum 
was added to the feeder layers and cultured with 5  X  IO4 normal 
BM cells as the target population. Both GM-CFC colony (>50  cells) 
and cluster (40  cells) formation was evaluated. 
GM-CSFprotein  assays.  BM  and  splenic GM-CSF protein were 
assayed using the Western dot blot technique. BM single-cell suspen- 
sions and splenic homogenates were placed on ice and disrupted by 
5 seconds of  sonication (Heat Systems Cell Disrupter with Microtip, 
Farmingdale, NY). The method of  Bradford16 was  used to determine 
protein concentrations. A modification of  the  method of Hawkes et 
all'  was used to determine the relative amounts of  GM-CSF in the 
cell homogenates. Briefly, 10 pg of total cellular protein was blotted 
onto a 0.45-pm nitrocellulose membrane (Schleicher & Schuell) for 
1 hour using a dot blotting apparatus (Bethesda Research Labora- 
tories). After blocking the nitrocellulose by incubation for 60 minutes 
at  room  temperature  with  phosphate-buffered saline  (PBS) con- 
taining 5% nonfat dried milk,  the  blot was incubated overnight at 
4°C  with  a goat polyclonal antibody against recombinant murine 
GM-CSF (R & D Systems, Minneapolis, MN) at 10 pg/mL in PBS/ 
5% bovine serum albumin (BSA) containing 0.1% thimerosal. The 
blot was washed three times (10 minutes each) in PBS/O.l% Tween- 
20 before incubating for 60 minutes at  room  temperature with  a 
1,000~  dilution of rabbit antigoat IgG horseradish peroxidase conju- 
gate (Sigma, St Louis, MO) in 1 YO  gelatin. The blot was then  washed 
six times (5 minutes each) in  PBS/O.I% Tween-20 before detection 
of  the peroxidase activity using the substrate 4-chloro-l-naphthol 
(Sigma) in the presence of hydrogen peroxide. After completion of 
the color reaction, the blots were washed with distilled water and 
dried. Serum GM-CSF protein was measured using a commercial 
enzyme-linked immunosorbent assay  (ELISA) kit  (Endogen, Inc, 
Boston, MA). Sera obtained from 10 normal or irradiated mice were 
pooled for use in this assay. Assays were performed according to 
the  manufacturer's  instructions after twofold dilution of  the  sera 
using the standard diluent supplied with the kit. 
Quanriration.  Each  sample's  densitometric  volume  was  measured 
using a scanning  laser densitometer  (Model  300B;  Molecular  Dynamics, 
Sunnyvale, CA) by  measuring  the  gray  density  of  the  entire PCR 
product  band  in  each  lane  or color  intensity  of  dot  blot  in  each  well. 
The  images  were  analyzed  using  ImageQuant  software  version  3.2 
* Spliced 
t Unspliced 
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Fig l.  BM (A) and splenic (B) cellular-*  in normal mice (NI and in irradiated mice on days 2,  4,7,  10,  14,  17,  and 21.  GM-CFC  recovery in 
BM  (C) and spleen (D) in normal (N)  and irradiated mice at days 7,10,14,17,  and 21 after 775  cGy MCo gamma exposure. Data represent  the 
mean f  SEM of  values obtained from  three experiments. *P < .05 with respect to normal control values. 
(Molecular  Dynamics),  which  was supplied  with  the  densitometer.  PCR 
product  and  protein  comparisons  were  then  based on  relative  expression 
differences  between  irradiated  and  control  samples. 
Statistics.  t-tests were  used  to  analyze  all  data.  Data  from  mRNA 
and  protein  experiments  are expressed as a  percentage of the  control 
value  for  each experiment (ie, percentage  of normal).  Data  were 
then  log transformed  before  calculating  means  and  standard  errors 
and  t-tests  were  performed  (in log units)  comparing  each  mean  with 
100% (normal controls). All P values  were  Bonferroni  corrected.  P 
values of less than .05 were  considered to  be  statistically  significant. 
RESULTS 
Radiation-induced  changes  in  cellularity.  Changes  in 
BM  and splenic cellularity after radiation are illustrated in 
Fig  1A and B.  The number of  BM  cells at days 2 and 4 
decreased to approximately 5.8% and 3.0%  of control mice, 
respectively. On subsequent days, a gradual recovery toward 
normal levels was observed; however, even at day 2  I  postir- 
radiation, BM cell numbers recovered to only 41.2% of  nor- 
mal controls. In  the spleen, cellularity decreased to  13.3% 
of  control values by  day 2 postirradiation and remained at 
approximately this level through day 10. However, between 
days 14 and 17 a dramatic recovery to normal levels occurred 
and progressed to supranormal levels at day 21  (156% of 
control values). 
Radiation-induced changes in GM-CFC progenitor cells. 
After irradiation, dramatic decreases in the number of GM- 
CFC progenitor cells in the BM and the spleen also occurred 
(Fig  1C and D).  BM  GM-CFC numbers were reduced to 
almost undetectable levels by day 7; by day 21 postirradia- 
tion, they had recovered to only 9.6% of  normal.  Splenic 
GM-CFC numbers were also reduced to almost undetectable 
levels by day 7; however, between days 14 and 17 a dramatic 
recovery to normal GM-CFC levels occurred that overshot 
normal levels by  5.8-fold  on day 21 postirradiation. 
Effects ofradiation  on  GM-CSFmRNA  levels.  Autoradio- 
graphs of  RT-PCR-amplified  GM-CSF mRNA transcripts 
of  BM  and spleen from one representative experiment are 
shown in Fig 2. The average relative GM-CSF mRNA levels 
obtained from four BM experiments and three spleen experi- 
ments are shown in Fig 3. BM GM-CSF mRNA levels were 
significantly  increased  by  day  2  and  remained  elevated 
through day  10  postirradiation. By  day  14, BM  GM-CSF 
mRNA  levels had  decreased  to  within the  normal  range. 
GM-CSF mRNA levels in the spleen were also significantly 
increased from day 4  to day 10  and also returned to normal 
levels by day 14 postirradiation. GAPDH mRNA levels were 
measured by simultaneous RT-PCR of  aliquots of  RNA from 
each specimen (data not shown). GAPDH mRNA levels did 
increase significantly to 'about 2.5 times normal  at  day 4  and 
7 after irradiation, but correction for these changes failed to 
explain the larger increases in GM-CSF transcript levels. 
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GM-CSF 
(B) Spleen 
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GM-CSF 
Fig 2.  Representative  autora- 
diographs of  RT-PCR-amplified 
mRNA  transcripts  of  GM-CSF 
and TGF-P in BM (A) and spleen  TG  F-p 
(B)  of normal mice (NI  and of irra- 
diated mice on days 2, 4.  7.  10, 
and 14 after 775 cGyQCo  gamma 
radiation  exposure.  Each  blot  N 
represents only one of three or 
four experiments performed for 
each  gene in each  tissue. 
Effects of  radiation on TGF-P mRNA levels.  Autoradio- 
graphs of RT-PCR-amplified  TGF-P mRNA transcripts of 
BM and  spleen  from  one representative experiment are also 
shown in Fig  2.  The average relative TGF-0 mRNA  levels 
obtained from three BM and spleen experiments are shown 
in Fig  4.  Compared  with  normal  controls,  no  significant 
differences in  either BM  or splenic TGF-P mRNA  levels 
were detected at  any  recovery  day after irradiation. 
Effects of  radiation on GM-CSF protein production.  Be- 
cause increased GM-CSF mRNA levels were observed after 
irradiation, it was thought that GM-CSF protein levels would 
also be  increased. Using  the Western dot blot technique, 
BM and splenic GM-CSF protein levels of  normal mice and 
irradiated mice on days 2,4, 7, IO,  and 14 postexposure are 
shown in Table 2. Surprisingly, BM  and splenic GM-CSF 
protein levels were not  significantly different from  normal 
controls at  any  recovery day after irradiation. GM-CSF levels 
were also evaluated in serum from normal mice and irradi- 
ated mice on days 2.4, 8, 10,  14, and  17 postexposure using 
an ELISA assay capable of detecting down to 3.9 pg/mL of 
murine GM-CSF. In  this assay, serum GM-CSF protein was 
also not detected (data not shown). However, sera from irra- 
diated mice were able to support GM-CFC colony and clus- 
ter formation to a much  greater extent than  normal  serum 
(Fig 5). 
DISCUSSION 
Hematopoietic recovery after sublethal myeloablative in- 
jury is  presumed  to  be mediated by endogenously produced 
2  4  7  10  14 
Days Postirradiation 
hematopoietic growth factors. In  this study, we  evaluated 
the effects of  a sublethal radiation exposure on  GM-CSF 
and TGF-P  mRNA levels. Because increases in GM-CSF 
message levels were detected, GM-CSF protein levels were 
also evaluated. To perform message evaluations, detection 
and semiquantitation for GM-CSF and TGF-P mRNA levels 
using the RT-PCR  method  and Southern blot analysis were 
established using as little as 0.1 pg of total  RNA.  This was 
critical  for  evaluations  in  radiation  studies  in which  cell 
numbers and  RNA  concentrations were extremely low  at 
days 2, 4, and 7 postirradiation, thus obviating the use of 
traditional techniques such as Northern blot and RNase pro- 
tection assays. 
Significant increases from  basal  GM-CSF mRNA levels 
occurred during the period  of  postirradiation hematopoietic 
regeneration, with BM  responses being more dramatic than 
those in the spleen. At days 2, 4, 7, and 10 postirradiation, 
BM GM-CSF mRNA levels increased approximately 1 I .6-, 
12.1-,  16.1-,  and  6.9-fold  over  normal  controls, whereas 
splenic GM-CSF mRNA levels at days 4.7, and 10 increased 
about 3.6-,  3.7-,  and  5.5-fold  over normal controls, respec- 
tively. By 2 weeks after irradiation, GM-CSF mRNA levels 
in both tissues had returned to  normal  levels. 
Because it was not  until  day  14 or later that significant 
BM  or splenic GM-CFC recovery  was detected in irradiated 
mice,  it appeared that GM-CSF mRNA expression preceded 
hematopoietic regeneration. However, despite the increase 
in the levels of GM-CSF mRNA in both BM and spleen, no 
increase in the levels of GM-CSF protein in BM, spleen, or 
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Fig 3.  BM  (A)  and  splenic (B) GM-CSF mRNA levels in normal  mice 
(NI and in irradiated  mice  on days 2, 4,  7,  10, and 14 after 775 cGy 
boCo  gamma exposure. Data are presented as the percentage of  nor- 
mal  control  levels and represent the mean ? SEM of values obtained 
from  four  BM experiments and  three splenic experiments.  *P < .05 
with respect to normal  control  values. 
serum could be detected  using  Western  dot blot and  ELlSA 
assays.  These  data  suggest  that GM-CSF  mRNA levels  have 
been  increased after irradiation  without an increase in protein 
production. Using  human  monocytes  stimulated with recom- 
binant  CSa. Geiger et allx have shown that  two  signals  are 
necessary for the  induction  of  IL-Io:  one  signal for transcrip- 
tional  activation  and  another signal for translational  activa- 
tion. It is possible that a similar mechanism is used for GM- 
CSF production. It is also possible that the increases in GM- 
CSF  mRNA  levels  observed in our  experiments  were  due 
simply to message stabilization. After irradiating CHU-2  and 
GCT cell  cultures,  Akashi  et al'" showed that  the  levels  of 
GM-CSF  mRNA  in these cells increased  at least partially due 
to stabilization  of  the GM-CSF  mRNA  and  were  specifically 
associated  with the  multiple  repeated  AUUUA motif  found 
in the 3'  untranslated  region  of  the GM-CSF mRNA.  The 
lack of  increased  GM-CSF protein  production  after  irradia- 
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Fig 4.  BM (A) and splenic (B) TGF-P  mRNA  levels in normal mice 
(NI and in irradiated  mice  on days 2, 4, 7,  10, and 14 after 775 cGy 
@'CO gamma exposure. Data are presented as the percentage of nor- 
mal  control  levels and represent the mean ? SEM of values obtained 
from  three experiments. 
tion in our  studies may also be the  result of altered  posttran- 
scriptional  processing. The  absence  of high molecular  weight 
RT-PCR GM-CSF products (data not shown) using primers 
that span  introns  rules  out altered  splicing  mechanisms.  Simi- 
Table 2.  Effects of a 775 cGy MCo Gamma Radiation Exposure on 
BM and Splenic GM-CSF Protein Levels in Mice 
Day Postirradiation  BM  Spleen 
2 
4 
7 
10 
14 
100.6 2 1.6 
100.3 rf  1.3 
97.9  -c  2.5 
102.3 !C  1.6 
98.9  ? 2.6 
102.2 ? 1.2 
101.8 2 2.0 
99.2 E 1.2 
97.9  z  1.5 
98.0 2 0.9 
Results are from densitometric analyses of Western dot blot. The 
values of GM-CSF protein are expressed as  a percentage of normal 
control values.  Data  represent the mean 2  SEM of values obtained 
from three experiments. 
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Fig 5.  Colony-stimulating  activity of 100 pL of serum from normal 
(NI and irradiated mice on days 2,4,8,  10, 14, and 17 after 775  cGy 
%o  gamma radiation exposure. Total GM-CFC  colony  and cluster 
formation (AI versus  GM-CFC  colony  formation (B). Data represent 
the mean ? SEM of  values  from triplicate plates in a single  experi- 
ment. 
My,  the use  of  poly  dT for priming of  the reverse tran- 
scriptase reaction  indicates that proper polyadenylation of 
the mRNA has taken place. Alternatively, GM-CSF protein 
may  be  produced but  is  secreted so rapidly that intracellular 
pools do not  appear to change. However, if that were the 
case,  it is  likely that  we  would  have  observed  increased 
levels of  GM-CSF  in the  sera  when  assayed by  ELISA, 
which  we  did  not. This then  would leave the remote possibil- 
ity that the secreted GM-CSF is  rapidly  bound  to the target 
cells and  turned over in a manner that makes it undetectable 
by  the assays used. Although we  did  not  detect GM-CSF 
proteins  in the serum of  irradiated mice using the ELISA 
assay, we  did detect colony-stimulating activity using a GM- 
CFC bioassay. However, increases in the levels of a number 
of  other cytokines could have produced this effect even in 
the absence of  GM-CSF.'"."  Finally, it is possible that GM- 
CSF may  play a minor role in the postirradiation recovery 
of hematopoietic cells. Studies by Neta et al"  evaluating the 
radioprotective effects of  LPS  and  IL-l  in the mouse have 
shown that treatment with GM-CSF antibodies does not det- 
rimentally affect LPS- and IL-l-induced  hematopoietic re- 
covery  and  mouse  survivability after irradiation. 
In  contrast to the results given above, we  observed no 
change in the levels of  TGF-/3  mRNA  in either the BM  or 
the spleen after irradiation when compared with unirradiated 
controls. Because both GM-CSF and  TGF-/3  are produced 
by similar cell types, these results suggest that  the observed 
increases in the levels of GM-CSF mRNA  in both  BM  and 
spleen  after  irradiation are  not  due  to  an  increase in the 
percentage of  cells producing GM-CSF in these organs but 
rather represent a genuine increase in the levels of  mRNA 
present in the cells. Although we cannot rule  out  the  level 
of  GM-CSF mRNA  per cell  remaining constant with  the 
level of TGF-/3  mRNA  decreasing, we consider this explana- 
tion to be unlikely given the nearly identical levels of  TGF- 
/3  in the control and experimental cell populations and  the 
known effects of increased stability of GM-CSF mRNA  after 
irradiation in in vitro studies. 
In  conclusion, we have shown  that  (I  ) using  RT-PCR we 
can  detect quantitative changes  in the levels of  GM-CSF 
mRNA  but  not  TGF-P  mRNA  in the  BM  and  spleen of 
irradiated mice relative to unirradiated mice; (2) the changes 
observed in the levels of GM-CSF mRNA  vary  in a tissue- 
and  time-specific manner; and  (3) the  levels of  GM-CSF 
protein in the  BM,  spleen, and serum do not  appear to in- 
crease after sublethal irradiation relative to controls. 
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